• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颞动脉炎(巨细胞动脉炎)的地理流行病学。

The geo-epidemiology of temporal (giant cell) arteritis.

作者信息

Lee Jennifer L, Naguwa Stanley M, Cheema Gurtej S, Gershwin M Eric

机构信息

Department of Internal Medicine, School of Medicine, University of California at Davis, Davis, CA 95616, USA.

出版信息

Clin Rev Allergy Immunol. 2008 Oct;35(1-2):88-95. doi: 10.1007/s12016-008-8075-0.

DOI:10.1007/s12016-008-8075-0
PMID:18286386
Abstract

Giant cell arteritis (GCA) is the most common vasculopathy in patients over the age of 50. The majority of data on the geo-epidemiology of GCA is derived from Scandinavia, although there is very good documentation and epidemiological descriptions from studies throughout Europe and North America. There remains, however, a paucity of data on the incidence and prevalence of GCA in North American minority populations, as well as from Africa or Asia. The data that does exist suggests that the incidence of GCA is lower in Hispanic, Asian, and African American populations. It is interesting to note that as the population throughout the world continues to age, we anticipate an increased prevalence of disease based upon increases in annual incidence and improved survival. Considerable research is still needed to identify genetic, environmental, and gender-specific factors that influence not only the etiology, but also the natural history of disease.

摘要

巨细胞动脉炎(GCA)是50岁以上患者中最常见的血管病。关于GCA地理流行病学的大多数数据来自斯堪的纳维亚半岛,尽管欧洲和北美的研究有非常完善的文献记录和流行病学描述。然而,关于北美少数族裔人群以及非洲或亚洲GCA发病率和患病率的数据仍然很少。现有的数据表明,西班牙裔、亚裔和非裔美国人中GCA的发病率较低。有趣的是,随着全球人口持续老龄化,基于年发病率的上升和生存率的提高,我们预计该病的患病率会增加。仍需要大量研究来确定不仅影响病因,而且影响疾病自然史的遗传、环境和性别特异性因素。

相似文献

1
The geo-epidemiology of temporal (giant cell) arteritis.颞动脉炎(巨细胞动脉炎)的地理流行病学。
Clin Rev Allergy Immunol. 2008 Oct;35(1-2):88-95. doi: 10.1007/s12016-008-8075-0.
2
A meta-analysis of the epidemiology of giant cell arteritis across time and space.巨细胞动脉炎的时空流行病学荟萃分析。
Arthritis Res Ther. 2021 Mar 11;23(1):82. doi: 10.1186/s13075-021-02450-w.
3
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.西班牙西北部经活检证实的巨细胞动脉炎的流行病学:18年期间的趋势
Ann Rheum Dis. 2001 Apr;60(4):367-71. doi: 10.1136/ard.60.4.367.
4
Giant cell arteritis in Jerusalem: a 12-year epidemiological study.
Br J Rheumatol. 1994 Oct;33(10):938-41. doi: 10.1093/rheumatology/33.10.938.
5
Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.1972-2012 年挪威西部巨细胞动脉炎的发病率:一项回顾性队列研究。
Arthritis Res Ther. 2017 Dec 15;19(1):278. doi: 10.1186/s13075-017-1479-6.
6
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.巨细胞动脉炎和风湿性多肌痛的发病率和患病率:系统文献回顾。
Semin Arthritis Rheum. 2020 Oct;50(5):1040-1048. doi: 10.1016/j.semarthrit.2020.07.005. Epub 2020 Jul 14.
7
The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations.耶路撒冷25年间巨细胞动脉炎的发病率:年度和季节性波动
Clin Exp Rheumatol. 2007 Jan-Feb;25(1 Suppl 44):S15-7.
8
Epidemiology of biopsy-proven giant cell arteritis in South Australia.南澳大利亚活检证实的巨细胞动脉炎的流行病学。
Intern Med J. 2014 Jan;44(1):32-9. doi: 10.1111/imj.12293.
9
[Epidemiology and etiological factors in giant cell arteritis (Horton's disease and Takayasu's disease)].[巨细胞动脉炎(霍顿病和高安病)的流行病学及病因学因素]
Ann Med Interne (Paris). 1998 Nov;149(7):425-32.
10
The incidence of giant cell arteritis in Slovenia.斯洛文尼亚巨细胞动脉炎的发病率。
Clin Rheumatol. 2019 Feb;38(2):285-290. doi: 10.1007/s10067-018-4236-6. Epub 2018 Jul 30.

引用本文的文献

1
Predictive biomarkers of response to tocilizumab in giant cell arteritis (GCA): correlations with imaging activity.巨细胞动脉炎(GCA)患者对托珠单抗应答的预测生物标志物:与影像学活动的相关性。
Immunol Res. 2024 Oct;72(5):1154-1160. doi: 10.1007/s12026-024-09518-0. Epub 2024 Aug 30.
2
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres.托珠单抗与甲氨蝶呤相比可更快实现巨细胞动脉炎的无类固醇缓解:两个参考中心的真实经验。
Intern Emerg Med. 2024 Nov;19(8):2177-2184. doi: 10.1007/s11739-024-03722-4. Epub 2024 Aug 2.
3
Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling.

本文引用的文献

1
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.美国关节炎及其他风湿性疾病患病率的估计。第二部分。
Arthritis Rheum. 2008 Jan;58(1):26-35. doi: 10.1002/art.23176.
2
Epigenetic clues to rheumatoid arthritis.类风湿关节炎的表观遗传学线索
J Autoimmun. 2008 Feb-Mar;30(1-2):12-20. doi: 10.1016/j.jaut.2007.11.006. Epub 2007 Dec 26.
3
Physiopathology of natural auto-antibodies: the case for regulation.天然自身抗体的生理病理学:调控的实例
巨细胞动脉炎的组织损伤的最新认识:从急性炎症反应到不适当的组织重塑。
Cells. 2024 Feb 29;13(5):430. doi: 10.3390/cells13050430.
4
New Insights into the Pathogenesis of Giant Cell Arteritis: Mechanisms Involved in Maintaining Vascular Inflammation.巨细胞动脉炎发病机制的新见解:维持血管炎症的相关机制
J Clin Med. 2022 May 20;11(10):2905. doi: 10.3390/jcm11102905.
5
Endovascular Therapy for Intracranial Giant Cell Arteritis : Systematic Review, Technical Considerations and the Effect of Intra-arterial Calcium Channel Blockers.颅内巨细胞动脉炎的血管内治疗:系统评价、技术考虑因素和动脉内钙通道阻滞剂的作用。
Clin Neuroradiol. 2022 Dec;32(4):1045-1056. doi: 10.1007/s00062-022-01171-0. Epub 2022 May 3.
6
Co-occurrence of unclassified myeloproliferative neoplasm and giant cell arteritis in a patient treated with allogeneic hematopoietic stem cell transplantation: a case report and literature review.异基因造血干细胞移植治疗患者中未分类骨髓增殖性肿瘤与巨细胞动脉炎的共存:一例报告及文献综述
Cent Eur J Immunol. 2021;46(1):121-126. doi: 10.5114/ceji.2019.83140. Epub 2021 Apr 18.
7
A meta-analysis of the epidemiology of giant cell arteritis across time and space.巨细胞动脉炎的时空流行病学荟萃分析。
Arthritis Res Ther. 2021 Mar 11;23(1):82. doi: 10.1186/s13075-021-02450-w.
8
Is There an Association between Herpetic Infections and Giant Cell Arteritis? A Population-Based Study.疱疹感染与巨细胞动脉炎之间存在关联吗?一项基于人群的研究。
J Clin Med. 2020 Dec 27;10(1):63. doi: 10.3390/jcm10010063.
9
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study.在巨细胞动脉炎起始时或极早期引入免疫抑制药物联合糖皮质激素的治疗策略:一项多中心回顾性对照研究
J Transl Autoimmun. 2020 Nov 28;3:100072. doi: 10.1016/j.jtauto.2020.100072. eCollection 2020.
10
PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.PET/CT 用于大血管血管炎的诊断和治疗。
Curr Cardiol Rep. 2019 Mar 18;21(5):34. doi: 10.1007/s11886-019-1122-z.
J Autoimmun. 2007 Dec;29(4):229-35. doi: 10.1016/j.jaut.2007.07.011.
4
Toll like receptors and autoimmunity: a critical appraisal.Toll样受体与自身免疫:批判性评估
J Autoimmun. 2007 Dec;29(4):310-8. doi: 10.1016/j.jaut.2007.09.001. Epub 2007 Oct 24.
5
The role of the innate immune response in autoimmune disease.先天性免疫反应在自身免疫性疾病中的作用。
J Autoimmun. 2007 Dec;29(4):206-12. doi: 10.1016/j.jaut.2007.07.018. Epub 2007 Sep 29.
6
Repertoire-dependent immunopathology.依赖于受体库的免疫病理学。
J Autoimmun. 2007 Dec;29(4):257-61. doi: 10.1016/j.jaut.2007.07.019. Epub 2007 Sep 21.
7
Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors.自身反应性B-1 B细胞:天然自身抗体B细胞抗原受体的限制因素
J Autoimmun. 2007 Dec;29(4):236-45. doi: 10.1016/j.jaut.2007.07.020. Epub 2007 Sep 21.
8
Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border.调节性T细胞在预防黏膜炎症性疾病中的作用:守护边界
J Autoimmun. 2007 Dec;29(4):272-80. doi: 10.1016/j.jaut.2007.07.021. Epub 2007 Sep 21.
9
Naturally occurring B-cell autoreactivity: a critical overview.天然存在的B细胞自身反应性:批判性综述。
J Autoimmun. 2007 Dec;29(4):213-8. doi: 10.1016/j.jaut.2007.07.010. Epub 2007 Sep 20.
10
Innate and adaptive immune response to apoptotic cells.对凋亡细胞的固有免疫和适应性免疫反应。
J Autoimmun. 2007 Dec;29(4):303-9. doi: 10.1016/j.jaut.2007.07.017. Epub 2007 Sep 20.